CVS Health Corporation CVS shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also raised FY21 EPS guidance above estimates.
The company reported first-quarter earnings per share of $2.04, which beat the $1.71 estimate, and sales results of $69.10 billion, which beat the $68.39 billion estimate.
The company also raised its full-year 2021 earnings per share guidance from $7.39-$7.55 to $7.56-$7.68 versus the $7.53 estimate.
CVS Health provides health services in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions.
CVS Health shares were trading 3% higher at $80.02 on Tuesday. The stock set a new 52-week high of $80.75 and has a 52-week low of $55.36.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.